Gossamer Bio, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · San Diego, CA
GOSS chart
What traders are saying about $GOSS
Latest postsGossamer Bio, Inc. news
- Gossamer Bio earnings missed by $3.57, revenue topped estimates
Investing.com Nigeria ·
- Gossamer Bio Reports Q3 2026 Revenue of $38.4 Million, Net Loss
GuruFocus ·
- Form 8K Gossamer Bio Inc For: 10 November By Investing.com
Investing.com Canada ·
- Gossamer Bio Q3 collaborator revenue jumps on Chiesi deal termination
TradingView ·
- Gossamer Bio Reports $38.4 Million Third-Quarter Revenue as Seralutinib NDA Submitted
Quiver Quantitative ·
- After a 46% workforce cut, Gossamer Bio (GOSS) warns about its ability to keep operating.
Stock Titan ·
- Gossamer Bio takes $25M upfront in deal tied to FDA review of lead drug
Dealroom ·
- Gossamer Bio: Q3 Earnings Snapshot
Yahoo Finance ·
- Gossamer Bio Announces Third Quarter 2026 Financial Results and Provides Business Update
Yahoo Finance ·
- Form 4 Gossamer Bio Inc: Faheem Hasnain (Director, President & CEO) For: 24 August
Investing.com Nigeria ·
- TG Therapeutics (TGTX) Beats Q3 Earnings and Revenue Estimates
Yahoo Finance ·
- Two holders each report 667,465 shares in Gossamer Bio (GOSS).
Stock Titan ·
Gossamer Bio, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $48.5M | $114.7M | $0 | $0 |
| Net income | -$170.4M | -$56.5M | -$179.8M | -$229.4M |
| Diluted EPS | $-0.75 | $-0.25 | $-1.18 | $-2.71 |
| Total assets (year end) | $172.2M | $315.3M | $311.9M | $272.4M |
| Cash and equivalents (year end) | $37.7M | $46.1M | $32.1M | $112.0M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Gossamer Bio, Inc.
- Ticker
- GOSS (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- San Diego, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1728117
Frequently asked questions
What exchange is Gossamer Bio, Inc. listed on?
Gossamer Bio, Inc. trades on the Nasdaq under the ticker symbol GOSS.
What industry is Gossamer Bio, Inc. in?
Gossamer Bio, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Gossamer Bio, Inc. headquartered?
Gossamer Bio, Inc.'s business address on file with the SEC is in San Diego, CA.
When does Gossamer Bio, Inc.'s fiscal year end?
Gossamer Bio, Inc.'s fiscal year ends on December 31.
How much revenue did Gossamer Bio, Inc. report?
Gossamer Bio, Inc. reported $48.5M in revenue for calendar year 2025, according to its SEC filings.